Hippocampal CA3 Transcriptome Signature Correlates with Initial Precipitating Injury in Refractory Mesial Temporal Lobe Epilepsy by Bando, Silvia Y. et al.
Hippocampal CA3 Transcriptome Signature Correlates
with Initial Precipitating Injury in Refractory Mesial
Temporal Lobe Epilepsy
Silvia Y. Bando1, Maryana C. Alegro2, Edson Amaro Jr3, Alexandre V. Silva4, Luiz H. M. Castro5, Hung-
Tzu Wen6, Leandro de A. Lima7, Helena Brentani8, Carlos Alberto Moreira-Filho1*
1Department of Pediatrics, Faculdade de Medicina da Universidade de Sa˜o Paulo (FMUSP), Sa˜o Paulo, Sa˜o Paulo, Brazil, 2 Laboratory of Integrated Systems, Escola
Polite´cnica da Universidade de Sa˜o Paulo, Sa˜o Paulo, Sa˜o Paulo, Brazil, 3Department of Radiology, Faculdade de Medicina da Universidade de Sa˜o Paulo (FMUSP), Sa˜o
Paulo, Sa˜o Paulo, Brazil, 4Department of Biosciences, Universidade Federal de Sa˜o Paulo, Santos, Sa˜o Paulo, Brazil, 5Clinical Neurology Division, Hospital das Clı´nicas da
Faculdade de Medicina da Universidade de Sa˜o Paulo, Sa˜o Paulo, Sa˜o Paulo, Brazil, 6 Epilepsy Surgery Group, Hospital das Clı´nicas da Faculdade de Medicina da
Universidade de Sa˜o Paulo, Sa˜o Paulo, Sa˜o Paulo, Brazil, 7 Laboratory of Biotechnology, Hospital do Caˆncer AC Camargo, Sa˜o Paulo, Sa˜o Paulo, Brazil, 8Department of
Psychiatry, Instituto Nacional de Psiquiatria do Desenvolvimento and Laborato´rio de Investigac¸a˜o Me´dica 23, Faculdade de Medicina da Universidade de Sa˜o Paulo
(FMUSP), Sa˜o Paulo, Sa˜o Paulo, Brazil
Abstract
Background: Prolonged febrile seizures constitute an initial precipitating injury (IPI) commonly associated with refractory
mesial temporal lobe epilepsy (RMTLE). In order to investigate IPI influence on the transcriptional phenotype underlying
RMTLE we comparatively analyzed the transcriptomic signatures of CA3 explants surgically obtained from RMTLE patients
with (FS) or without (NFS) febrile seizure history. Texture analyses on MRI images of dentate gyrus were conducted in a
subset of surgically removed sclerotic hippocampi for identifying IPI-associated histo-radiological alterations.
Methodology/Principal Findings: DNA microarray analysis revealed that CA3 global gene expression differed significantly
between FS and NFS subgroups. An integrative functional genomics methodology was used for characterizing the relations
between GO biological processes themes and constructing transcriptional interaction networks defining the FS and NFS
transcriptomic signatures and its major gene-gene links (hubs). Co-expression network analysis showed that: i) CA3
transcriptomic profiles differ according to the IPI; ii) FS distinctive hubs are mostly linked to glutamatergic signalization
while NFS hubs predominantly involve GABAergic pathways and neurotransmission modulation. Both networks have
relevant hubs related to nervous system development, what is consistent with cell genesis activity in the hippocampus of
RMTLE patients. Moreover, two candidate genes for therapeutic targeting came out from this analysis: SSTR1, a relevant
common hub in febrile and afebrile transcriptomes, and CHRM3, due to its putative role in epilepsy susceptibility
development. MRI texture analysis allowed an overall accuracy of 90% for pixels correctly classified as belonging to FS or
NFS groups. Histological examination revealed that granule cell loss was significantly higher in FS hippocampi.
Conclusions/Significance: CA3 transcriptional signatures and dentate gyrus morphology fairly correlate with IPI in RMTLE,
indicating that FS-RMTLE represents a distinct phenotype. These findings may shed light on the molecular mechanisms
underlying refractory epilepsy phenotypes and contribute to the discovery of novel specific drug targets for therapeutic
interventions.
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Introduction
Epilepsy affects 50 million people worldwide, 80% of them
living in developing countries, and about 30% of the patients did not
achieve remission with the available anti-epileptic drugs [1]. Mesial
temporal lobe epilepsy (MTLE) is the most common partial epilepsy
in adults and hippocampal sclerosis (HS) constitutes its most
frequent pathological abnormality [2]. MTLE is often resistant to
antiepileptic drugs (refractory epilepsy) and is associated with a
history of prolonged febrile seizures (PFS) in childhood or other
initial precipitating injuries [2,3–5].
A large body of experimental data on how antecedent febrile
seizures lead to MTLE emerged from studies on animal models of
inflammation- and hyperthermia-induced seizures [6–10]. Some
of these studies combined in vitro and animal models in order to
check for pre-existing factors, such as ion channel mutations,
cortical dysplasia or brain injuries. These factors may explain
some but not the vast majority of MTLE cases in which children
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without any identifiable predisposing factor had PFS and further
developed epilepsy. Experimental investigations also focused seizure
duration, showing that in animal models PFS determines an
increased risk for developing MTLE [8,9]. This has been confirmed
by clinical research, thus indicating that aborting febrile seizures to
prevent status epilepticus is an important preventive approach [11].
Subsequently, experimental evidences rendered clear that MTLE
arises after febrile seizures through a succession of events, probably
starting with the release of inflammatory mediators, what is later
followed by cell loss at the hippocampus, mesial temporal sclerosis
and neuronal circuitry remodeling [10,12,13].
Therefore, the molecular pathomechanisms involved in PFS-
induced MTLE would be provoked by inflammatory mediators
and then driven by coordinate changes in the expression of
hundreds of genes in the brain. With the aim of characterizing
these transcriptional changes, DNA microarray methodologies
were employed in a variety of animal model studies [7], together
with genetic linkage studies conducted in familial PFS-cases [14].
However, for obtaining predictive biomarkers of epileptogenesis
and identifying novel therapeutic targets it is mandatory to
conduct gene expression studies on surgical specimens obtained
from the hippocampi of patients submitted to epilepsy surgery
[5,15].
Patients with refractory MTLE (RMTLE) generally undergo
epilepsy surgery and brain explants obtained through this
procedure are a valuable material for investigating the molecular
mechanisms underlying refractory epilepsy. Studies in surgical
specimens helped to reveal the pivotal role of the hippocampus for
temporal lobe epilepsies and, particularly, of the dentate gyrus in
several biological processes related to the startup and to the end
stages of the disease [16]. Pathomorphological studies showed
compromised neurogenesis and significant dentate granule cell loss
in children and adult patients presenting temporal lobe epilepsy
[17–19].
In order to gain a better understanding on the biological and
molecular mechanisms governing RMTLE, several authors
conducted gene expression studies on surgical specimens obtained
from the hippocampus and entorhinal cortex of patients submitted
to epilepsy surgery [20–23]. These studies, recently reviewed by
Wang et al. [5], brought an impressive amount of information but
also showed low consistence of data among different laboratories.
In order to overcome this flaw those authors suggested that
genomic profile studies should be centered in specific anatomic
subregions of the hippocampus. Moreover, due to the importance
of the initial precipitating injury (IPI) in MTLE development, a
comparative analysis of cases with and without prolonged febrile
seizure history would be very relevant. Here we pursued this kind
of analysis by studying the transcriptomic profile of hippocampal
CA3–CA4 transition explants obtained surgically from patients
with RMTLE and HS with (FS) or without (NFS) a history of
febrile seizures as the IPI. High-resolution 3T magnetic resonance
imaging (MRI) texture analysis was employed in order to assess
IPI-related differences in the surgical removed hippocampi of FS
and NFS patients. A summary of the study work-flow is depicted in
Figure 1.
Results
Patients’ clinical and pathological data
A total of 23 patients with refractory epilepsy and mesial
temporal sclerosis who underwent corticoamygdalohippocampect-
omy were included in this study. Their main clinical features are
summarized in Table 1. None of these patients presented any
evidence of mental retardation or had first-degree family members
with epilepsy or febrile seizure history. Eight patients with well
characterized antecedent prolonged febrile seizures that occurred
within 6 months and 4 yrs of age were classified as FS cases. The
average and standard error for disease onset age and IPI in this
Figure 1. Study work-flow. During epilepsy surgery tissue explants from CA3 were obtained for genomic studies. The entire hippocampus was
then resected and the specimen was submitted to MRI for texture analysis of the dented gyrus (DG) and, subsequently, to global histological analysis.
Arrowed dotted lines indicate PHG-CA1 input-output trajectory. The blue dotted line indicates CA3 and DG limits. Abbreviations: SUB subiculum; GCL,
granule cell layer.
doi:10.1371/journal.pone.0026268.g001
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subgroup were 761.8 yrs. and 260.5 yrs. respectively. The
remaining patients had no history of febrile IPI (NFS cases) and
their average and standard error for t disease onset age and IPI
were 11.961.8 yrs. and 8.862.2 respectively. Patient’s age at
surgery ranged from 13 to 57 years (mean age 32 years). Average
duration of epilepsy before surgery was 21.966 years for FS and
22.162.2 years for NFS cases. Genomic studies of hippocampal
CA3 encompassed 6 FS and 12 NFS cases. MRI studies included 4
FS and 8 NFS cases.
Histopathology
It was possible to confirm in all cases that tissue sampling for
genomic analysis corresponded more precisely to the CA3–CA4
transition (Figure 2 A–C). Typical aspects of hippocampal sclerosis
were observed for all cases, including gliosis and neuronal cell loss
in CA1, CA3 and hilus of the dentate gyrus (CA4), with a relative
preservation of CA2 and subicullum. In the granule cell layer
(Figure 2 D–F) neuronal cell loss was significantly higher (p,0.05)
in FS cases (Figure S1, supporting information), whereas no
significant differences between FS and NFS were found for cell
dispersion and bilamination.
MRI texture analysis
A computational pipeline combining MRI high resolution
acquisitions, image processing, texture analysis and pattern
classification algorithms was used for image-based identification
of histological features in the sclerotic hippocampi of 4 FS and 8
NFS cases. Classification procedures focused: i) cell loss and
dispersion; ii) comparison between specimens from patients with
or without antecedent febrile seizures history. The overall
accuracies for correctly classified pixels were 90% for cell loss,
84% for cell dispersion and 90% for correlation with febrile
history, thus showing that MRI texture features correlate with IPI.
Transcriptome profile analysis
The comparison of CA3 global gene expression data between
FS and NFS subgroups was performed using SAM procedure (5%
false discovery rate) and yielded a total of 511 differentially
expressed transcripts, all up-regulated (fold $3.0) in the FS
subgroup. A subset of 335 genes annotated with Gene Ontology
(GO) categories were found among these transcripts. Hierarchical
clustering, performed by means of the TMEV 4.6.1 program, is
presented as supporting information (Figure S2).
Transcriptional interaction analysis
This analysis was accomplished using SAM-selected up-
regulated GO annotated genes and the FunNet software. The
strength of the links between each pair of genes was given by
Spearman’s correlation coefficient for expression profiles. The
relevant biological themes, annotating differentially expressed
Table 1. Patients’ clinical and pathological data.
Epilepsy Age at
Patient Febrile IPI onset duration surgery
ID Gender FRc seizure (yr/mo) (yr) (yr) (yr) Side
FS1a M no yes 4 4 9 13 right
FS2a M no yes 1/8 7 18 25 left
FS3b F no yes 1 8 11 19 right
FS4a M no yes 4 4 26 30 right
FS5b M 3rd yes 0/6 15 14 29 left
FS6a F no yes 2 14 5 19 right
FS7a,b M 2nd yes 2 2 37 39 left
FS8a,b F no yes 0/6 2 55 57 right
NFS9a F no no 7 7 21 28 left
NFS10a M no no 1/6d 5 27 32 left
NFS11a F no no 4d 4 19 23 left
NFS12a F no no 13 13 29 42 left
NFS13b M no no 0/9d 8 20 28 left
NFS14b F 2nd no 7 7 23 30 right
NFS15a,b M 3rd no 3 14 17 31 left
NFS16a,b F 2nd no 29 29 15 44 left
NFS17a,b F 2nd no 2 11 28 39 left
NFS18a M no no 1 12 29 41 left
NFS19a,b M no no 8 8 21 29 right
NFS20a,b M no no 3 7 23 30 right
NFS21b M 2nd no 21d 23 10 33 right
NFS22a F 2nd no 18 18 7 25 left
NFS23a,b F 3rd no 13 13 42 55 right
FR, familial recurrence; acase included in genomic analysis; bcase included in MRI studies; csecond or dthird degree relative with epilepsy; ehead trauma.
doi:10.1371/journal.pone.0026268.t001
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genes, were indicated by significantly overrepresented categories
from the GO Biological Processes (Figure 3). The overall
distributions of the annotated genes by each GO category for FS
and NFS subgroups appear as supporting information in Tables
S1 and S2.
Figures 3A and 3B show the GO Biological Processes theme
proximity networks for FS and NFS subgroups in that order. Intra-
and inter-module links are indicated by solid or dotted lines,
respectively. Although both networks comprised in essence the
same themes, the sequence and link strengths of theme interactions
were rather different. FS theme network was formed around three
distinct modules: module 1 (triangle) displayed a theme cluster
centered in synaptic transmission and ion transport; module 2
(square) was mainly related to dopamine signaling pathway,
sodium ion transport and transmembrane transport; and module 3
(circle) was linked to glutamate signaling pathway and regulation
of neuronal excitability. In the NFS network five distinct modules
were formed (Figure 3B): modules 1 and 3 are mostly linked to
synaptic plasticity and neurotransmitter transport, respectively;
modules 2 and 4 are related to nervous system development and
glutamate signaling pathway; and module 5 contains biological
themes related to axonogenesis, ion transport and synaptic
transmission.
The transcriptional interaction networks, or co-expression
networks, for FS and NFS subgroups, depicted in Figures 4A
and 4B respectively, were based on significantly over-represented
GO Biological Processes categories. This analysis was accom-
plished using the Spearman’s co-expression correlation for
differentially expressed genes; therefore both networks were
formed by the same set of differentially expressed genes. Co-
expression coefficients $0.85, corresponding to 870 out of 4,186
links between each pair of genes, were selected for FS network.
The NFS network was constructed adopting co-expression
coefficients from 0.14 up to 0.70, corresponding to 518 out
4,186 links. In these networks the most relevant genes, or hubs, are
the ones with the highest number of gene-gene links, graphically
represented by the proportionally larger nodes. The number of
gene-gene links distributed by link strength categories for FS and
NFS subgroups is shown in Fig. 5. A list of the most relevant hubs
according to the number of gene-gene links appears in Table 2,
together with their respective biological functions.
FS co-expression network
The gene CACNG2 formed the major hub (91 gene-gene links)
and it was exclusive of this network. This gene codes for stargazin,
a transmembrane receptor regulatory protein involved in the
control of surface and synaptic expression of the excitatory
AMPA-type glutamate receptors [24,25]. The gene SSTR1 was
the second FS major hub (76 gene-gene links) and, interestingly, it
was also the major hub of the NFS network (see below). This gene
is very relevant for epilepsy since it codes for a receptor of the
endogenous antiepileptic somatostatin [26,27]. The third FS
major hub (65 gene-gene links) was the gene NELL1 (neural
epidermal growth factor-like 1, [28], which codes for a protein
firstly found in neuroblastoma cell lines and possibly involved in
controlling neural differentiation [29].
Two significant secondary hub clusters were identified in the FS
network. One of these clusters, in which all hubs had 55 gene-gene
links, comprised: i) the genes encoding the voltage-gated potassium
(KCNMA1) and sodium (SCN3B) channels [30,31]; ii) SLC32A1, a
gene coding for a vesicular GABA transporter [32]; iii) D4S234E,
alias NEEP21, which codes for a protein with a pivotal role in the
hippocampal recycling and internalization of AMPA-receptors
[33,34]; iv) LPPR4, a gene involved in the modulatory control of
hippocampal excitability, preventing hyperexcitability in glutamaer-
gic neurons [35]; v) SLC2A3, alias GLUT3, the main neuronal
glucose-transporter [36]; vi) YWHAH, a candidate gene for
autosomal dominant familial partial epilepsy with variable foci [37],
which codes for a neural protein that mediates signal transduction by
binding to phosphoserine-containing proteins [38,39] and vii)
MYT1L, a zinc finger gene involved in the recruitment of histone
deacetylase to regulate neural transcription [40].
The other cluster, with 49 gene-gene links per hub, included
genes codifying for voltage-gated potassium (KCNQ2, [41]) and
sodium (SCN4B, [42]; SCN9A, [43]) channels and for the GABAA
receptor subunit (GABRB3, [44]), plus the genes BAIAP2, which
codes for an adaptor protein highly expressed at postsynaptic
density of excitatory synapses, regulating dendritic spine morpho-
Figure 2. Tissue sampling and histopathological results. In A, surgical view of the hippocampus: (1) body of the hippocampus/CA1; (2) head
of the hippocampus; (3) dentate gyrus/fimbria (green dot); (4) parahippocampal gyrus (blue dot). B, MRI of surgically resected hippocampus; C– F
Nissl-stained hippocampal slices. In B and C the location of tissue resection for genomic analysis is marked with an asterisk showing the resection in
the CA3–CA4 transition. D–F Cytoarchitectural alterations of the granule cell layer in sclerotic hippocampi. D: cell dispersion. E: bilamination. F: cell
loss. Calibration bar = 100 microns.
doi:10.1371/journal.pone.0026268.g002
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genesis and density [45], ISLR2, involved in the modulation of
growth factor signals during neural development [46] and
MFSD4, which codes for a protein (major facilitator superfamily
domain containing 4) that interacts with ELK transcription factors
(up-regulated by nerve damage) in several regions of the nervous
system [47].
Figure 3. Theme proximity network analysis for GO biological processes categories. Thematic maps for FS and NFS subgroups appear in
A and B respectively.
doi:10.1371/journal.pone.0026268.g003
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Figure 4. Transcriptional interaction analysis for GO molecular processes. Transcriptional interaction networks for FS and NFS subgroups
appear in A and B respectively.
doi:10.1371/journal.pone.0026268.g004
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NFS co-expression network
Here the gene SSTR1 appeared again as a major hub (50 links),
but together with FGF13 (52 links), which codes for a voltage-
gated sodium channel modulator [48] and is involved in nervous
system development [49], BSN (47 links), that codes for Bassoon, a
protein engaged in organizing Ca2+ channel clustering, synaptic
vesicle docking and speeding of synapse reloading at excitatory
synapses [50,51] and CHRM3 (39 links), a muscarinic acetylcho-
line receptor involved in the cholinergic neuromodulation of
hippocampal circuitry [52].
Two relevant secondary hub clusters, predominantly related to
NFS thematic modules 2 (nervous system development) and 5
(axonogenesis, ion transport), were identified in this network. One
was formed around the gene SLC12A5 (42 links), alias KCC2, a gene
encoding the neuron-specific K-Cl cotransporter involved in the
modulation of GABA-ergic transmission [53] and with a central role
in promoting inhibition and preventing hyperexcitability in human
hippocampus [54,55]. The other was centered in SVOP (37 links), a
gene encoding for a transporter-like protein localized to neurotrans-
mitter-containing vesicles [56]. The SLC12A5 cluster included
MTY1L, the axonogenesis-related gene CCK [57], KCNQ2 and
CACNA1I, which codes for a T-type calcium channel [58]. The
SVOP cluster contained as significant hubs the genes NELL1 and
KARLN [59], both related to neural development, and SNAP25, a
member of the SNARE superfamily involved in the regulation of
synaptic vesicle exocytosis [60]. Additionally, overall gene-gene link
strength was diminished in relation to the values observed for the FS
network (see Figure. 5), possibly reflecting higher phenotypic and
clinical heterogeneities among afebrile cases. The significance of these
findings for clarifying the molecular pathomechanisms involved in
RMTLE and for the identification of novel and/or phenotype-
specific therapeutic target candidates will be discussed below.
qPCR Validation
In order to validate the DNA microarray data five up-regulated
genes - NELL1, NEURL, NEUROD6, SVOP and SYT1 - were
selected for real-time quantitative PCR (qPCR) analysis. The fold-
changes for each gene, comparing FS versus NFS group’s average rela-
tive gene expression, confirmed DNA microarray results (Figure S3).
Discussion
Through the use of a systems biology approach, based on the
comparative analysis of CA3 transcriptional interaction networks
from RMTLE patients with (FS) or without (NFS) antecedent
childhood febrile seizures, we were able to demonstrate that febrile
and afebrile RMTLE constitute two distinct genomic phenotypes.
MRI texture analysis of dentate gyrus also differentiated FS and
NFS subgroups and histological examination showed higher
neuronal cell loss in FS hippocampi, thus representing a
morphological counterpart for the genomic findings. The unique-
ness of FS genomic signature is supported by a recent epidemiologic
survey on temporal lobe epilepsy (TLE) patients with (TLE-FS) or
without (TLE-NFS) early childhood febrile seizures based on age of
onset, seizure type and ictal symptoms and familial recurrence, that
placed TLE-FS as phenotype distinct from afebrile TLE [61].
Similar conclusions came from a study of neuropathologic features
of resected hippocampi from RMTLE patients where morpholog-
ical alterations such as cell genesis and granule cell dispersion
correlate with febrile IPI [62]. Therefore, the above-mentioned
genomic and clinicopathological evidences confirm early clinical,
imaging and epidemiological observations [3,10,63–66] pointing
out to the relevance of febrile IPI in RMTLE.
Co-expression network analyses of FS and NFS transcriptomes
revealed relevant commonalities and differences. The most striking
commonality involves the gene SSTR1, a major hub in both
networks. The SSTR gene family codes for the brain receptors of
somatostatin (SST), a potent endogenous antiepileptic [26]. In
rodents SST acts on dentate gyrus, CA1 and CA3 reducing
epileptiform events. Therefore SST receptors expressed in these
hippocampal areas are considered potential therapeutic targets for
treating refractory temporal lobe epilepsy [27]. In rodents receptor
subtypes 2 and 4 appear to mediate the majority of the
antiepileptic actions of somatostatin [27]. In humans there are
five SSTR genes [67] and SSTR2 was found to be downregulated
in CA1 and CA3 hippocampal explants surgically obtained from
patients with temporal lobe epilepsy, probably reflecting increased
neural cell loss in these areas and also the SSTR2 involvement in
antiepileptic processes [68]. Here we show that SSTR1, which is
known to be expressed in human fetal central nervous system [69],
is also expressed in CA3 hippocampal region of patients with
RMTLE. Thus SSTR1 and its product could be thus considered
as potential therapeutic targets in RMTLE.
Two genes related to nervous system development, MYT1L and
NELL1, also appeared as significant hubs in both networks.
MYT1L is a neural specific zinc finger gene regulating neuronal
transcription [40,70], oligodendrocyte differentiation [71] and
cortical neuron progenitor development [72]. NELL1 codes for a
protein containing EGF-like repeats and its expression has been
detected in fetal brain [28] and in central nervous system tumors
[29], being probably active in controlling neural differentiation
pathways. To our knowledge, this is the first description of the
expression of both genes in human CA3 hippocampal cells. This
expression could interpreted as compensatory to the decreased
hippocampal neurogenesis observed in temporal lobe epilepsy
[18,19], which is particular severe in dentate gyrus and CA1 and
CA3 in RMTLE [62]. Several strategies have been devised to
augment neurogenesis in the dentate gyrus in temporal lobe
epilepsy [19]. However, it seems unsafe to consider MYT1L and
NELL1 in the scenario of gene therapy: the first has a widespread
role in controlling neural differentiation processes through gene
silencing [40] and the former is related to neoplastic processes in
the brain. Moreover, there always the risk of promoting erroneous
incorporation of newly formed neurons in hippocampal circuitry
[19]. The same rationale discussed above applies to the nervous
system development-related hubs ISLR2 and BAIAP2 in the FS
network, as well as to the NFS axonogenesis-related secondary
hubs CCK and KARLN.
Figure 5. Gene-gene link strength category distribution.
Number of gene-gene links distributed by link strength categories for
FS (red bar) and NFS (blue bar).
doi:10.1371/journal.pone.0026268.g005
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The significant hub differences among FS and NFS interaction
networks encompass genes that fall in two main categories:
modulators of neurotransmission and modulators of intrinsic
membrane excitability. The modulators of neurotransmission
include genes related to i) glutamatergic pathways and excitatory
transmission; ii) GABAergic transmission and iii) synaptic
transmission. These hub differences and their biological signifi-
cance are briefly discussed below.
Table 2. Main hubs in FS and/or NFS transcriptional interaction networks.
Number of
Gene gene-gene links Gene product and/or biological function Refsb
FS NFS
CACNG2 91 nonea stargazin; 24
transmembrane AMPA receptor regulatory protein
SSTR1 76 50 somatostatin receptor 1 27
NELL1 65 29 neural differentiation control 29
SLC32A1 55 9 GABA vesicular transporter 32
MYT1L 55 32 regulation of neurotranscription & neural differentiation 40
KCNMA1 55 21 calcium-ativated potassium channel 30
YWHAH 55 10 mediation of signal transduction in neurons; 37
synaptic transmission
SLC2A3 55 Nonea alias GLUT3; main neuronal glucose transporter 36
SCN3B 55 Nonea sodium channel beta 3 subunit; sodium ion transport 31
D4S234E 55 8 alias NEEP21; AMPA receptor recycling in neurons 34
LPPR4 55 24 (alias PRG1) 35
control of hippocampal excitatory transmission
KCNQ2 49 27 voltage-gated potassium channel 41
SCN4B 49 8 voltage-gated sodium channel type IV, beta 42
SCN9A 49 11 voltage-gated sodium channel type IX 43
MFSD4 49 1 major facilitator superfamily containing domain 4,
involved in nerve damage repair 47
ISLR2 49 1 modulation of growth factors signals during 46
neural development
BAIAP2 49 7 regulation of dendritic spine morphogenesis and density 45
GABRB3 49 5 GABA(A) receptor (GABAR) beta 3 subunit 44
FGF13 10 52 (alias FHF2) biding/modulation of voltage-gated sodium 48,49
channel;nervous system development
CHRM3 11 39 cholinergic neuromodulation of hippocampal circuitry 52
BSN 18 47 (Bassoon) speeding of vesicle reloading at 51
excitatory synapses
SLC12A5 10 42 (alias KCC2) potassium-chloride cotransporter; 54
modulation of neuronal excitability
CCK 18 31 output regulation of distinct types of inhibitory 57
interneurons in the hippocampus
SVOP 18 37 transporter-like protein that localize to 77
neurotransmitter-containing vesicles
KARLN 3 25 Kalirin, brain-specific guanine-nucleotide exchange 59
factor (GEF) for the Rho family of small GTPases;
maintenance of hippocampal pyramidal neuron dendrites
and dendritic spines
SNAP25 10 25 SNARE superfamily protein; regulation of synaptic 60
vesicle exocytosis
CACNA1I 10 25 Voltage-dependent calcium channel controlling 58
rapid entry of Ca(2+)
aLink strength coeficient ,0.10. bReferences. Bold numbers indicate hubs in FS and/or NFS subgroups.
doi:10.1371/journal.pone.0026268.t002
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The genes acting on glutamatergic pathways and excitatory
transmission have more relevance (considering gene-gene links) in
the FS network, forming two of its major and exclusive hubs,
namely CACNG2 (stargazin) and SLC2A3 (alias GLUT3). The
first is essential for stabilizing diffuse AMPA receptors in the post
synaptic density, an important feature of glutamatergic synaptic
transmission [73]. The second is the main neuronal glucose
transporter and modulates brain glucose uptake, being therefore
relevant for excitatory transmission processes [74]. The genes
D4S234 (alias NEEP21), involved in AMPA receptor recycling in
neurons [33] and LPPR4 (alias PRG1), a controller of hippocam-
pal excitatory transmission [35] also constitute major FS hubs
related to neurotransmission modulation (Table 2), whereas BSN,
a gene engaged in the speeding of vesicle reloading at excitatory
synapses [50] is the sole major NFS hub in this group, with LPPR4
constituting a secondary hub.
Regarding the modulators of GABAergic transmission, the
major FS hubs are GABRB3, a gene coding a GABAA receptor
subunit and in which mutations are known to cause childhood
absence epilepsy [44], and SLC32A1, that codes for a vesicular
GABA transporter [32]. In the NFS network the epilepsy-
associated gene SLC12A5 (alias KCC2) appears as a very relevant
hub. KCC2 by governing cellular chloride concentrations enables
GABA-A receptor activation to hyperpolarize the cell and may
represent an intrinsic antiepileptogenic mechanism [75] Loss of
KCC2 may render activation of the receptor depolarizing.
Reduction of its expression in subicular regions adjacent to
sclerotic areas of the hippocampus has been associated to
epileptiform activity [55].
The four genes related to neurotransmission modulation form
relevant hubs only in the NFS co-expression network. Three of
these genes are involved with synaptic vesicle function: SVOP, a
nucleotide and ion transporter-protein [76,77]; SNAP-25, a
fundamental component of the SNARE complex used for fast
synaptic communication in excitatory and inhibitory circuits [60]
and BSN, that codes for Bassoon, a protein engaged in the
speeding of synapse reloading at excitatory synapses [50,51]. The
fourth gene in this group is CHRM3, is a muscarinic acetylcholine
receptor that confers differential cholinergic modulation to
neurochemically distinct hippocampal basket cell subtypes [52].
Interestingly, early life seizures appear to increase the efficacy of
muscarinic receptors coupling to protein G accounting for adult
susceptibility to epilepsy, what makes this gene a potential target
for novel anticonvulsant drugs [78].
In the category of modulators of intrinsic membrane excitabil-
ity, the FS network has as significant hubs KCNMA1, a gene
involved in the regulation of action potential in neurons and whose
defective expression plays a critical role in the pathogenesis of
mesial temporal lobe epilepsy [30] and SCN3B, which codes for a
calcium-activated potassium channel and whose downregulation is
associated to hippocampal sclerosis [23,31]. Interestingly, this gene
has 55 gene-gene links in the FS network but none in the NFS
(Table 2). Also in the FS network are the genes SCN4B/ SCN9A,
involved in sodium ion transport, and KCNQ2, a voltage-gated
potassium channel, all relevant for the regulation of neuronal
excitability. The NFS network displays in this category only two
significant hubs formed by the genes FGF13, a voltage-gated
calcium channel modulator, and CACNA1I, a calcium-signaling
gene responsible for neuronal excitation [79].
The general picture that emerges from the analysis of co-
expression networks shows that the FS distinctive hubs are mostly
linked to glutamatergic signalization while in the NFS network the
majority of the distinctive hubs involve GABAergic pathways and
neurotransmission modulation. Both networks have relevant hubs
related to nervous system development, what is consistent with the
cell genesis activity described in the hippocampus of RMTLE
patients [19,62]. Moreover, two candidate genes for therapeutic
targeting came out from this analysis: SSTR1, a relevant common
hub in febrile and afebrile transcriptomes, and CHRM3, due to its
putative role in epilepsy susceptibility development.
In conclusion, the experimental design of this work, centered on
the comparative studies of CA3 transcriptome and of dentate gyrus
morphological features, was instrumental for characterizing febrile
RMTLE as a distinct phenotype. The co-expression network analysis
permitted to reveal molecular mechanisms underlying the refractory
epilepsy phenotypes, pointing out two potential therapeutic targets
represented by the genes SSTR1 and CHRM3. Furthermore, the
biological system approach adopted here proved to be a powerful tool
for exploring the intricacies of the epilepsy molecular mechanisms,
allowing the functional profiling of a large set of genomic data.
Methods
Patients
The RMTLE patients included in this study were selected
through the CInAPCe-FAPESP Program (www.fapesp.br/en/;
www.cinapce.org.br), the largest Brazilian research program on
epilepsy and neuroimaging. This research has been approved by
the research ethics committees of Hospital das Clı´nicas da FMUSP
and of Hospital Albert Einstein under numbers 251/05 and CAEE
0122.0.028.174.05 respectively. A written informed consent was
obtained from all patients. Refractory epilepsy cases were defined
as those who have not gained seizure control after treatment with
three or more anticonvulsant drugs. All patients were submitted to
clinical, electrophysiological, neuropsychological and neuroimag-
ing evaluations before surgery. The patients were submitted to
epilepsy surgery between February 2009 and August 2010.
Brain tissue specimens for gene expression and
neuropathological studies
Fresh ex-vivo explants from hippocampal CA3 of our patients
were obtained at the surgery room (Figure 2A) and immediately
preserved with RNAlater (Qiagen cat. no. 76106, Valencia, CA).
The entire hippocampus was then removed. MRI and histological
studies were accomplished in all removed hippocampi for
neuropathology analysis and for confirming that the explants for
gene expression were obtained at the proper site (Figure 2B–C).
RNA extraction
Brain tissue explants from CA3 (3–4 mm3) were homogenized
with TissueRupter (Qiagen, cat. no. 9001272 Valencia, CA) and
total RNA was extracted from the homogenates using the RNeasy
Lipid Tissue Kit (Qiagen cat. no. 74804, Valencia, CA) according
to the manufacturer’s instructions. RNA quality was assessed on the
Agilent BioAnalyzer 2100 (Agilent, Santa Clara, CA). All samples
were stored at 280uC until used in hybridization experiments.
Microarray hybridization and gene expression analysis
In order to determine gene expression profiles, 44 K DNA
microarrrays (Agilent Technologies, cat no. G4845A Santa Clara,
CA) were used. The procedures for hybridization followed the
protocols provided by the manufacturer’s instructions (One-Color
Microarray-Based Gene Expression Analysis - Quick Amp
Labeling). The images were captured by the reader Agilent
Bundle according to the parameters recommended for bioarrays
and extracted by Agilent Feature Extraction software version
9.5.3. Among the 45,015 spots present in each array only those
with none or only one flag (i.e. low intensity, saturation, controls,
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etc.) were selected for analysis using the R software version 2.11.1
(R Development Core Team, 2010) and the Lowess test for
normalization. We identified 28,546 valid transcripts for the CA3
samples (6 FS and 12 NFS patients). By means of the TMEV
software version 4.6.1 [80] we selected differentially expressed
transcripts using the Significance Analysis of Microarrays (SAM)
procedure, a statistical technique for finding significant genes in a
set of microarray experiments [81]. The input data is gene
expression measurements from a set of microarray experiments, as
well as a response variable from each experiment. It uses repeated
permutations of the data to determine if the expressions of any
genes are significantly related to the response. The cutoff for
significance is determined by a tuning parameter delta, chosen by
the user based on the false discovery rate. Here we used a 5% false
discovery rate.
Hierarchical clustering was based on Pearson correlation and
complete linkage. All microarray raw data has been deposited in
GEO public database (http://www.ncbi.nlm.nih.gov/geo), a
MIAME compliant database, under accession number GSE28674.
Transcriptional interaction analyses (GO and Network
analysis)
We used the FunNet software (http://www.funnet.info) - based
on the Gene Ontology Consortium (GO, http://www.geneontology.
org) genomic annotations - for performing the functional profiling of
gene expression data and identifying the biological themes and gene-
gene interactions in which the differentially expressed genes are
involved. The parameters used in these analyses were Spearman co-
expression correlation and 5% false discovery rate. Themes with
significant relationship in the transcriptional expression space were
associated to build transcriptional modules in a proximity network. A
transcriptional interaction network, corresponding to the theme
proximity network, was then obtained. Data analysis and visualiza-
tion were accomplished through Cytoscape (version 2.8.0, www.
cytoscape.org).
qPCR
Differential gene expression data were validated through
quantitative real-time polymerase chain reaction (qPCR). Specific
primers for five selected genes (Table S3) were designed using the
Primer-BLAST (Primer3 Input, version 0.4.0 and BLAST, available
at http://www.ncbi.nlm.nih.gov/tools/primer-blast/). All samples
were amplified in triplicates. Amplification reactions were performed
in a 25 uL final volume containing 1X SYBR Green mix (Quantitec
SYBR Green PCR kit, QIAGEN, Hilden, DE), 10 pmol of each primer
and 2 mL cDNA (1/10 dilution, synthesized from 1 mg of total
RNA). Real time PCR amplifications were performed in Applied
Biosystems StepOne Plus Real Time PCR System with StepOne
software (Applied Biosystems, Forrest City, CA, USA) with the
following cycling parameters: an initial hot start of 95uC for 15 min
followed by 50 cycles of 95uC for 15 s and 60uC for 30 s. In order to
normalize qPCR reactions, GAPDH was included as reference gene
after checking that amplification curves for different 12 different
CA3 RNA samples (6 from FS and 6 from the NFS patients) yielded
essentially the same results. Relative expression was determined by
the relative standard curve method and presented as fold change
comparing FS versus NFS mean values.
Neuropathology
Specimens obtained during epilepsy surgery were fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer for 24 h and then
transferred to a solution of PF 1% plus sucrose 30% in PB 0.1 M
for one week. Each hippocampus (25–30 mm length) was carefully
oriented, trimmed and sectioned in the plane perpendicular to its
longitudinal axis. The entire hippocampus (head and body) was
used in the present investigation (50–60 slices/patient). Because
sections cut tangentially to the principal cell layers or at inconsistent
angles from the longitudinal axis of the hippocampus can produce
unusual histological features, considerable care was taken to ensure
that all hippocampal sections were cut in a plane strictly
perpendicular to the longitudinal axis of the hippocampus. Sixty-
micron coronal slices through the entire extension of the
hippocampus were obtained using a cryostat (221uC). One out
five slices were mounted on glass slides and stained with cresyl violet
(Nissl). The histological pattern described in the [82] atlas was used
to identify the normal cytoarchitectural features in every hippo-
campal section.
Semi-quantitative assessment of sclerotic hippocampi was made
for each histological slice focusing on dentate gyrus abnormalities
at hippocampal body. The following parameters were evaluated:
gliosis, neuronal cell loss and cytoarchitectural disorganization
(dispersion and bilamination). These features were graded from
zero (no abnormality) to 3 (very intense abnormality). An
additional grade 4 was included for neuronal cell loss, indicating
absence of neurons in the region under examination. The mean
value for each parameter was calculated in each individual case.
Bilamination of granular cell layer was described as present (yes) or
absent (no). Statistical analysis was accomplished using non-
parametric Mann-Whitney t-test, p,0.05.
Dentate Gyrus MRI texture analysis
Image acquisitions of 12 hippocampi surgically obtained from 4
FS and 8 NFS cases (see Table 1) were performed in a 3.0T
SIEMENS Magnetom TIM Trio scanner (80 cm bore, 40 mT/m,
230 mT/m/s) using a surface coil (‘‘Loop 7’’). Images were
acquired with the hippocampus immersed in 1% paraformalde-
hyde in 0.1 M phosphate buffer, inside a BD FalconTM 50 cc
conical tube. High-resolution images were acquired using a TSE
(Turbo Spin Echo) protocol, with TR = 3700 ms, TE = 76 ms, fat
sat by IR, TF = 7, FA = 180, BW = 40, FOV = 43 mm (70% AP
phase oversampling), a 5126512 matrix, slice thickness of 1.6 mm
and 32 NEX. Attained in-plane resolution is 80 mm680 mm and
CNR = 15. In order to guide data extraction, regions of interest
covering the dentate gyrus were manually drawn over the MRI
images by a neuropathologist. Imaging data was then processed in
a pipeline [83] consisting of preprocessing (noise filtering,
background segmentation, intensity normalization), feature ex-
traction (texture calculation) and analysis (data randomization,
data resampling, and classification). Feature extraction was
performed with the aid of a 969 points sliding window using a
set of 150 texture parameters calculated for every pixel in the
image, namely: co-occurrence matrix parameters [84]; run-length
matrix parameters [85]; wavelet parameters [86]; fractal dimen-
sion [87]; Markov random field parameters [88] and Gabor filter
parameters [89,90].?A data matrix containing texture information
from the dentate gyrus of FS and NFS patients was assembled
using Matlab (http://www.mathworks.com/products/matlab/).
Classification procedures were executed using a random forest
algorithm and the Weka [91] data mining workbench. Since the
number of NFS patients was larger, the matrix was processed so to
keep the number of samples equal for both classes thus avoiding
bias in the classification.?Results were attested using a 10-fold
cross-validation methodology, where the entire data set is divided
in 10 partitions and the process of training/testing is repeated 10
times. In each turn the classifier was calculated for 9 partitions and
tested for the remaining one. The final results are the mean output
of each turn. The kappa statistics was used to verify if the
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agreement between classification and true classes exceeds chance
levels. Values higher than zero indicate that the classification
results were not merely caused by chance. Finally, a Receiver
Operator Characteristic (ROC) curve was used to assess the
quality of the trained classifier. A detailed description of the use of
this methodology for assessing hippocampal sclerosis in MTLE will
appear in another paper of our group headed by MC Alegro.
Supporting Information
Figure S1 Dentate gyrus histological features. Neuronal
cell loss and cell dispersion values are shown for FS (gray) and NFS
(white) tissue samples. Histological features were graded from zero
(no abnormality) to 3 (very intense abnormality).
(TIF)
Figure S2 Hierarchical clustering for differential ex-
pressed genes. Pearson correlation hierarchical clustering of
335 differentially expressed annotated genes across the FS and
NFS subgroups.
(TIFF)
Figure S3 qPCR validation of DNA microarray data. In
A the boxplots comparing the DNA microarray expression values
of five selected genes in FS (gray) and NFS (white) samples. In B
qPCR expression fold changes comparing FS X NFS samples for
the same genes showing upregulation in FS.
(TIF)
Table S1 Gene classification in GO Biological Process for FS
group.
(DOC)
Table S2 Gene classification in GO Biological Process for NFS
group.
(DOC)
Table S3 Primer sequences used for validation of gene
expression by qPCR.
(DOC)
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